Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,026) with videos related to
Page
of 103
Sort By:
Cell Reports. Medicine
|
April 22, 2026
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity
Yifei Ma, Ao Zhang, Jiacai Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 13, 2021
Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study
Qing-Lei Zeng, Hong-Xu Zhang, Ji-Yuan Zhang, et al.
The American Journal of Gastroenterology
|
October 9, 2024
Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial
Qing-Lei Zeng, Yi-Hua Zhou, Xiao-Ping Dong, et al.
Nature
|
April 22, 2026
Multicentre gene therapy for OTOF-related deafness followed up to 2.5 years
Luoying Jiang, Xiaoting Cheng, Jun Lv, et al.
Aging Cell
|
May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in Multicohorts
Zhiyu Wu, Shanshan Wu, Shuyao Song, et al.
The Lancet. Respiratory Medicine
|
July 22, 2019
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
Juncheng Dai, Jun Lv, Meng Zhu, et al.
Cell
|
January 7, 2022
Limb development genes underlie variation in human fingerprint patterns
Jinxi Li, James D Glover, Haiguo Zhang, et al.
Signal Transduction and Targeted Therapy
|
August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
Med (New York, N.Y.)
|
October 24, 2025
International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials
Xintai Fan, Ziwen Gao, Jiake Zhong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 15, 2021
Polygenic risk scores for prediction of breast cancer risk in Asian populations
Weang-Kee Ho, Mei-Chee Tai, Joe Dennis, et al.
Page
of 103
Search research articles
Search
Showing results (1011-1020 of 1,026) with videos related to
Sort By:
Page
of 103
Cell Reports. Medicine
|
April 22, 2026
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity
Yifei Ma, Ao Zhang, Jiacai Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 13, 2021
Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study
Qing-Lei Zeng, Hong-Xu Zhang, Ji-Yuan Zhang, et al.
The American Journal of Gastroenterology
|
October 9, 2024
Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial
Qing-Lei Zeng, Yi-Hua Zhou, Xiao-Ping Dong, et al.
Nature
|
April 22, 2026
Multicentre gene therapy for OTOF-related deafness followed up to 2.5 years
Luoying Jiang, Xiaoting Cheng, Jun Lv, et al.
Aging Cell
|
May 31, 2026
Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in Multicohorts
Zhiyu Wu, Shanshan Wu, Shuyao Song, et al.
The Lancet. Respiratory Medicine
|
July 22, 2019
Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
Juncheng Dai, Jun Lv, Meng Zhu, et al.
Cell
|
January 7, 2022
Limb development genes underlie variation in human fingerprint patterns
Jinxi Li, James D Glover, Haiguo Zhang, et al.
Signal Transduction and Targeted Therapy
|
August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
Med (New York, N.Y.)
|
October 24, 2025
International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials
Xintai Fan, Ziwen Gao, Jiake Zhong, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 15, 2021
Polygenic risk scores for prediction of breast cancer risk in Asian populations
Weang-Kee Ho, Mei-Chee Tai, Joe Dennis, et al.
Page
of 103